Who Paid My Doc
John Halloran
Diagnostic Radiology Waterloo, IA Medical Doctor
NPI 1821044587 CMS profile 1069934
1825 Logan Ave, Waterloo, IA 50703
General payments
$993
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, John Halloran of Waterloo, IA is reported in the CMS Open Payments database as having received $993 across 21 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 79th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $139 | 1 | |
| 2023 | General | $281 | 5 | |
| 2022 | General | $165 | 3 | |
| 2021 | General | $208 | 9 | |
| 2020 | General | $161 | 2 | |
| 2019 | General | $39 | 1 |
Beside peers
- John Halloran
- Diagnostic Radiology median
- Middle half of Diagnostic Radiology
- National median
In program year 2025, general payments to John Halloran were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.
Show as a table
| Year | John Halloran | Diagnostic Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $39 | $108 | $29–$318 | $163 |
| 2020 | $161 | $65 | $21–$252 | $114 |
| 2021 | $208 | $92 | $24–$292 | $132 |
| 2022 | $165 | $104 | $29–$294 | $149 |
| 2023 | $281 | $110 | $29–$337 | $160 |
| 2024 | $139 | $113 | $30–$356 | $164 |
| 2025 | $0 | $112 | $32–$349 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 110 billing codesPaid by Medicare
$32,283
Medicare patients
893
Services billed
1,217
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 54% | |
| Ischemic heart disease | 43% | |
| Chronic kidney disease | 41% | |
| Diabetes | 37% | |
| Heart failure | 33% | |
| Depression | 33% | |
| Atrial fibrillation | 30% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
21 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Diagnostic Radiology in Iowa
Paul Jabour
Diagnostic Radiology · Clive, IA
Andrea Lamphiear
Diagnostic Radiology · Iowa City, IA
Stuart Lehr
Diagnostic Radiology · Clive, IA
Michael Hummel
Diagnostic Radiology · Iowa City, IA
Joshua Rosebrook
Diagnostic Radiology · West Des Moines, IA
Sarah Pauley
Diagnostic Radiology · Cedar Rapids, IA
Related records
Diagnostic Radiology in Iowa
Practitioners in the same specialty and state, ranked by reported value.
All Diagnostic Radiology
Everyone recorded under this specialty, nationwide.
Doctors in Iowa
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.